Prevalence of bronchial hyperresponsiveness to 4.5% saline and its relation to asthma and allergy symptoms in Austrian children

The prevalence of asthma in school children has been reported to have increased, with wide variations between countries. To allow comparison of prevalence data, objective markers of asthma should be measured. Therefore, we assessed the prevalence of bronchial hyperresponsiveness (BHR) to hypertonic saline and its relation to asthma and allergy symptoms in 507 Austrian school children, aged 12-15 yrs in a cross-sectional, community based survey. These children were selected from 3,371 children who had answered a self-administered written questionnaire on asthma, hay fever, eczema and environmental factors. The prevalence of BHR to hypertonic saline was 14% and the majority (70%) of the children had mild BHR. The prevalence of wheeze in the last 12 months was 12% and of a diagnostic label of asthma was 6%. Fifty three per cent of the children with symptoms in the last 12 months and a diagnostic label of asthma had BHR, and 33% of those with symptoms in the last 12 months regardless of a diagnostic label of asthma showed a positive response to hypertonic saline. Atopic dermatitis, a diagnostic label of asthma, night cough apart from colds, wheeze in the past 12 months (but not "former wheeze") and male gender were significantly associated with increased response to 4.5% saline in the final logistic regression model. These results show that the prevalence of asthma symptoms in the last 12 months and the prevalence of bronchial hyperresponsiveness to hypertonic saline are twice that of a diagnosis of asthma and that asthma might be underdiagnosed in the present population. The response to hypertonic saline is most strongly associated with current asthma and allergy symptoms. A combination of a "diagnostic label of asthma" and "asthma symptoms in the last 12 months" might best reflect "current asthma" in epidemiological studies in this population.

This article has been cited by other articles:

				A. Zacharasiewicz, N. Wilson, C. Lex, E. M. Erin, A. M. Li, T. Hansel, M. Khan, and A. Bush Clinical Use of Noninvasive Measurements of Airway Inflammation in Steroid Reduction in Children Am. J. Respir. Crit. Care Med., May 15, 2005; 171(10): 1077 - 1082. [Abstract] [Full Text] [PDF]

				D. C. Grootendorst and K. F. Rabe Mechanisms of Bronchial Hyperreactivity in Asthma and Chronic Obstructive Pulmonary Disease Proceedings of the ATS, April 1, 2004; 1(2): 77 - 87. [Abstract] [Full Text] [PDF]

				P. J. Cooper, M. E. Chico, M. Bland, G. E. Griffin, and T. B. Nutman Allergic Symptoms, Atopy, and Geohelminth Infections in a Rural Area of Ecuador Am. J. Respir. Crit. Care Med., August 1, 2003; 168(3): 313 - 317. [Abstract] [Full Text] [PDF]

				B. Niggemann, S. Illi, C. Madloch, K. Volkel, S. Lau, R. Bergmann, E. von Mutius, U. Wahn, and MAS-Study Group Histamine challenges discriminate between symptomatic and asymptomatic children Eur. Respir. J., February 1, 2001; 17(2): 246 - 253. [Abstract] [Full Text] [PDF]